Literature DB >> 7316962

The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

K J Gadd, K B Reid.   

Abstract

Preformed immune aggregates, containing antigen and either IgG (immunoglobulin G) or F(ab')2 rabbit antibody, were incubated with normal human serum under conditions allowing activation of only the alternative pathway of complement. Both the IgG and F(ab')2 immune aggregates bound C3b, the activated form of the complement component C3, in a similar manner, 2-3% of the C3 available in the serum being bound to the aggregates as C3b, and the rest remaining in the fluid phase as inactive C3b or uncleaved C3. It was found that the C3b was probably covalently bound to the IgG in the aggregates, since C3b-IgG complexes could be demonstrated on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, after repeated washing with buffers containing high salt or boiling under denaturing conditions. Incubation of the C3b-antibody-antigen aggregates in buffers known to destroy ester linkages had little effect on the C3b-IgG complexes, which suggested that C3b and IgG might be linked by an amide bond. Two main types of C3b-IgG complexes were found that had apparent mol.wts. of 360000 and 580000, corresponding to either one to two C3b molecules respectively bound to one molecule of antibody. On reduction of the C3b-IgG complexes it was found that the beta-chain, but not the alpha'-chain, of C3b was released along with all the light chain of IgG but only about half or less of the heavy chain of IgG. These results indicate that, during activation of the alternative pathway of complement by immune aggregates containing IgG antibody, the alpha'-chain of C3b may become covalently bound at one or two sites in the Fd portion of the heavy chain of IgG.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316962      PMCID: PMC1162911          DOI: 10.1042/bj1950471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

2.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Structural studies of products of antigen-antibody-complement interaction.

Authors:  P C Chan; J J Cebra
Journal:  Immunochemistry       Date:  1968-01

4.  Two complement interaction sites in guinea pig immunoglobulins.

Authors:  A L Sandberg; B Oliveira; A G Osler
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

5.  Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.

Authors:  S I Chung; M S Lewis; J E Folk
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

6.  A comparison of methods for the molecular quantitation of the fourth component of human complement.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1968-03

7.  Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.

Authors:  A P Dalmasso; H J Müller-Eberhard
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

8.  Variation in the N-terminal sequence of heavy chains of immunoglobulin G from rabbits of different allotype.

Authors:  J M Wilkinson
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

9.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  48 in total

1.  Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.

Authors:  E Jelezarova; A Vogt; H U Lutz
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation.

Authors:  Hans U Lutz; Peter J Späth
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Specificity of bovine serum antibody to capsular carbohydrate antigens from Pasteurella haemolytica.

Authors:  D S McVey; R W Loan; C W Purdy; W J Shuman
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells.

Authors:  Hans U Lutz
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

5.  Limulus alpha 2-macroglobulin. First evidence in an invertebrate for a protein containing an internal thiol ester bond.

Authors:  P B Armstrong; J P Quigley
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

6.  Common evolutionary origin of alpha 2-macroglobulin and complement components C3 and C4.

Authors:  L Sottrup-Jensen; T M Stepanik; T Kristensen; P B Lønblad; C M Jones; D M Wierzbicki; S Magnusson; H Domdey; R A Wetsel; A Lundwall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Sequence determination of the thiolester site of the fourth component of human complement.

Authors:  R A Harrison; M L Thomas; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Authors:  Celene M O S Alves; Cleni M Marzocchi-Machado; Paulo Louzada-Junior; Ana Elisa C S Azzolini; Ana Cristina M Polizello; Ivan F de Carvalho; Yara M Lucisano-Valim
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

9.  Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

Authors:  R D Campbell; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

10.  Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes.

Authors:  L F Fries; S A Siwik; A Malbran; M M Frank
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.